These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31266140)

  • 41. Patient and provider perspectives on implementation barriers and facilitators of an integrated opioid treatment and HIV care intervention.
    Cooke A; Saleem H; Hassan S; Mushi D; Mbwambo J; Lambdin B
    Addict Sci Clin Pract; 2019 Jan; 14(1):3. PubMed ID: 30691511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review.
    Rosso A; Pitini E; D'Andrea E; Massimi A; De Vito C; Marzuillo C; Villari P
    Ann Ig; 2017; 29(5):464-480. PubMed ID: 28715059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A theoretical analysis of the barriers and facilitators to the implementation of school-based physical activity policies in Canada: a mixed methods scoping review.
    Weatherson KA; Gainforth HL; Jung ME
    Implement Sci; 2017 Mar; 12(1):41. PubMed ID: 28347322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetics, Screening, and Treatment of Familial Hypercholesterolemia: Experience Gained From the Implementation of the Vietnam Familial Hypercholesterolemia Registry.
    Truong TH; Do DL; Kim NT; Nguyen MT; Le TT; Le HA
    Front Genet; 2020; 11():914. PubMed ID: 32922439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spectrum of mutations of familial hypercholesterolemia in the 22 Arab countries.
    Alhababi D; Zayed H
    Atherosclerosis; 2018 Dec; 279():62-72. PubMed ID: 30415195
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implementation of the BETTER 2 program: a qualitative study exploring barriers and facilitators of a novel way to improve chronic disease prevention and screening in primary care.
    Sopcak N; Aguilar C; O'Brien MA; Nykiforuk C; Aubrey-Bassler K; Cullen R; Grunfeld E; Manca DP
    Implement Sci; 2016 Dec; 11(1):158. PubMed ID: 27906041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative aspects of the care of familial hypercholesterolemia in the "Ten Countries Study".
    Pang J; Chan DC; Hu M; Muir LA; Kwok S; Charng MJ; Florkowski CM; George PM; Lin J; Loi DD; Marais AD; Nawawi HM; Gonzalez-Santos LE; Su TC; Truong TH; Santos RD; Soran H; Tomlinson B; Yamashita S; Ademi Z; Watts GF
    J Clin Lipidol; 2019; 13(2):287-300. PubMed ID: 30797720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland.
    Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M
    Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The economic impact of hypercholesterolemia and mixed dyslipidemia: A systematic review of cost of illness studies.
    Ferrara P; Di Laura D; Cortesi PA; Mantovani LG
    PLoS One; 2021; 16(7):e0254631. PubMed ID: 34252164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk Communication in Families of Children with Familial Hypercholesterolemia: Identifying Motivators and Barriers to Cascade Screening to Improve Diagnosis at a Single Medical Center.
    Wurtmann E; Steinberger J; Veach PM; Khan M; Zierhut H
    J Genet Couns; 2018 Aug; ():. PubMed ID: 30109451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Real-world utilization of guideline-directed genetic testing in inherited cardiovascular diseases.
    Longoni M; Bhasin K; Ward A; Lee D; Nisson M; Bhatt S; Rodriguez F; Dash R
    Front Cardiovasc Med; 2023; 10():1272433. PubMed ID: 37915745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A qualitative study to identify barriers and facilitators to implementation of pilot interventions in the Veterans Health Administration (VHA) Northwest Network.
    Sharp ND; Pineros SL; Hsu C; Starks H; Sales AE
    Worldviews Evid Based Nurs; 2004; 1(2):129-39. PubMed ID: 17129326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Understanding the dissemination of appointment-based synchronization models using the CFIR framework.
    Patterson J; Holdford D
    Res Social Adm Pharm; 2017; 13(5):914-921. PubMed ID: 28595895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP
    JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Barriers, facilitators, and recommendations related to implementing the Baby-Friendly Initiative (BFI): an integrative review.
    Semenic S; Childerhose JE; Lauzière J; Groleau D
    J Hum Lact; 2012 Aug; 28(3):317-34. PubMed ID: 22628290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care.
    Alonso R; Perez de Isla L; Muñiz-Grijalvo O; Mata P
    Vasc Health Risk Manag; 2020; 16():11-25. PubMed ID: 32021224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deploying Clinical Decision Support for Familial Hypercholesterolemia.
    Bangash H; Sutton J; Gundelach JH; Pencille L; Makkawy A; Elsekaily O; Dikilitas O; Mir A; Freimuth R; Caraballo PJ; Kullo IJ
    ACI open; 2020 Jul; 4(2):e157-e161. PubMed ID: 36644330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integrating Patient-Reported Outcomes Into Clinical Genetic Testing for Familial Hypercholesterolemia.
    Hendricks-Sturrup RM; Block R; Lu CY
    J Patient Cent Res Rev; 2021; 8(4):336-339. PubMed ID: 34722802
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.